1. Home
  2. TECX vs PKOH Comparison

TECX vs PKOH Comparison

Compare TECX & PKOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • PKOH
  • Stock Information
  • Founded
  • TECX 2019
  • PKOH 1907
  • Country
  • TECX United States
  • PKOH United States
  • Employees
  • TECX N/A
  • PKOH N/A
  • Industry
  • TECX
  • PKOH Industrial Specialties
  • Sector
  • TECX
  • PKOH Industrials
  • Exchange
  • TECX Nasdaq
  • PKOH Nasdaq
  • Market Cap
  • TECX 334.4M
  • PKOH 282.2M
  • IPO Year
  • TECX 2018
  • PKOH N/A
  • Fundamental
  • Price
  • TECX $21.51
  • PKOH $18.30
  • Analyst Decision
  • TECX Buy
  • PKOH
  • Analyst Count
  • TECX 6
  • PKOH 0
  • Target Price
  • TECX $79.20
  • PKOH N/A
  • AVG Volume (30 Days)
  • TECX 172.8K
  • PKOH 27.9K
  • Earning Date
  • TECX 05-08-2025
  • PKOH 05-06-2025
  • Dividend Yield
  • TECX N/A
  • PKOH 2.77%
  • EPS Growth
  • TECX N/A
  • PKOH 144.68
  • EPS
  • TECX N/A
  • PKOH 2.26
  • Revenue
  • TECX N/A
  • PKOH $1,644,000,000.00
  • Revenue This Year
  • TECX N/A
  • PKOH $1.80
  • Revenue Next Year
  • TECX N/A
  • PKOH $4.21
  • P/E Ratio
  • TECX N/A
  • PKOH $6.17
  • Revenue Growth
  • TECX N/A
  • PKOH N/A
  • 52 Week Low
  • TECX $13.70
  • PKOH $17.58
  • 52 Week High
  • TECX $61.07
  • PKOH $34.50
  • Technical
  • Relative Strength Index (RSI)
  • TECX 51.42
  • PKOH 38.19
  • Support Level
  • TECX $21.20
  • PKOH $17.77
  • Resistance Level
  • TECX $22.75
  • PKOH $20.64
  • Average True Range (ATR)
  • TECX 1.43
  • PKOH 0.71
  • MACD
  • TECX 0.01
  • PKOH -0.13
  • Stochastic Oscillator
  • TECX 41.32
  • PKOH 17.97

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.

Share on Social Networks: